Trial intelligence / Profile preview

Chambá tincture for systemic arterial hypertension

RBR-5tsy7yxPhase 3Not yet recruiting

Sponsor
Faculdade de Medicina de Ribeirão Preto
Start
Jul 2021
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in systemic arterial hypertension (HTN) (2 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Planned start Jul 2021; status: not yet recruiting.

02

Conditions

systemic arterial hypertension (HTN)

Beyond the preview

Go deeper on RBR-5tsy7yx.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-5tsy7yx.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call